Franck Viguié.ABCB1 (неопр.). Atlas of Genetics and Cytogenetics in Oncology and Haematology (1 марта 1998). Дата обращения: 2 марта 2008. Архивировано 20 июля 2011 года.
doi.org
doi.org
Wolking S, Schaeffeler E, Lerche H, Schwab M, Nies AT (July 2015). "Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature". Clinical Pharmacokinetics. 54 (7): 709—35. doi:10.1007/s40262-015-0267-1. PMID25860377. S2CID35961181.
Ferreira RJ, Ferreira MJ, Dos Santos DJ (June 2012). "Insights on P-Glycoprotein's Efflux Mechanism Obtained by Molecular Dynamics Simulations". Journal of Chemical Theory and Computation. 8 (6): 1853—64. doi:10.1021/ct300083m. PMID26593820.
Schinkel AH (April 1999). "P-Glycoprotein, a gatekeeper in the blood-brain barrier". Advanced Drug Delivery Reviews. 36 (2—3): 179—194. doi:10.1016/S0169-409X(98)00085-4. PMID10837715.
dx.doi.org
PDB3G60; Aller S.G., Yu J., Ward A., Weng Y., Chittaboina S., Zhuo R., Harrell P.M., Trinh Y.T., Zhang Q., Urbatsch I.L., Chang G. Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding (англ.) // Science : journal. — 2009. — March (vol. 323, no. 5922). — P. 1718—1722. — doi:10.1126/science.1168750. — PMID19325113. — PMC2720052.
Abdallah M., Al-Abd A. M., El-Dine R. El-Halawany S.Ali M. P-glycoprotein inhibitors of natural origin as potential tumor chemo-sensitizers: A review
Author links open overlay panelHossam (англ.) // Journal of Advanced Research. — 2015. — Vol. 6, no. 1. — P. 45—62. — doi:10.1016/j.jare.2014.11.008.
Wolking S, Schaeffeler E, Lerche H, Schwab M, Nies AT (July 2015). "Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature". Clinical Pharmacokinetics. 54 (7): 709—35. doi:10.1007/s40262-015-0267-1. PMID25860377. S2CID35961181.
Ferreira RJ, Ferreira MJ, Dos Santos DJ (June 2012). "Insights on P-Glycoprotein's Efflux Mechanism Obtained by Molecular Dynamics Simulations". Journal of Chemical Theory and Computation. 8 (6): 1853—64. doi:10.1021/ct300083m. PMID26593820.
Schinkel AH (April 1999). "P-Glycoprotein, a gatekeeper in the blood-brain barrier". Advanced Drug Delivery Reviews. 36 (2—3): 179—194. doi:10.1016/S0169-409X(98)00085-4. PMID10837715.
ncbi.nlm.nih.gov
PDB3G60; Aller S.G., Yu J., Ward A., Weng Y., Chittaboina S., Zhuo R., Harrell P.M., Trinh Y.T., Zhang Q., Urbatsch I.L., Chang G. Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding (англ.) // Science : journal. — 2009. — March (vol. 323, no. 5922). — P. 1718—1722. — doi:10.1126/science.1168750. — PMID19325113. — PMC2720052.
PDB3G60; Aller S.G., Yu J., Ward A., Weng Y., Chittaboina S., Zhuo R., Harrell P.M., Trinh Y.T., Zhang Q., Urbatsch I.L., Chang G. Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding (англ.) // Science : journal. — 2009. — March (vol. 323, no. 5922). — P. 1718—1722. — doi:10.1126/science.1168750. — PMID19325113. — PMC2720052.
semanticscholar.org
api.semanticscholar.org
Wolking S, Schaeffeler E, Lerche H, Schwab M, Nies AT (July 2015). "Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature". Clinical Pharmacokinetics. 54 (7): 709—35. doi:10.1007/s40262-015-0267-1. PMID25860377. S2CID35961181.
Franck Viguié.ABCB1 (неопр.). Atlas of Genetics and Cytogenetics in Oncology and Haematology (1 марта 1998). Дата обращения: 2 марта 2008. Архивировано 20 июля 2011 года.